More specifically, PD-L1 expression on APCs in the TEM, particularly macrophages and DCs, rather than cancer cell-intrinsic PD-L1, has been suggested to account for the potential therapeutic efficacy of PD-1/PD-L1 signaling blockade [46]. Here, CD274 is linked to cancer.